Cure Pharmaceuticals shareholders will vote on a proposal to double the company’s shares of common stock from 75 million to 150 million and its common stock available for awards from 5 million to 10 million at its 2019 annual shareholders meeting on July 15 in Oxnard. In a pre-proxy statement filed after markets closed June…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
